Skip to main content
Top
Published in: BMC Infectious Diseases 1/2003

Open Access 01-12-2003 | Research article

Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study

Authors: Janet M Wojcicki, Rob Newton, Margaret I Urban, Lara Stein, Martin Hale, Moosa Patel, Paul Ruff, Ranjan Sur, Dimitra Bourboulia, Freddy Sitas

Published in: BMC Infectious Diseases | Issue 1/2003

Login to get access

Abstract

Background

Infection with human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the necessary causal agent in the development of Kaposi's sarcoma (KS). Infection with HIV-1, male gender and older age all increase risk for KS. However, the geographic distribution of HHV-8 and KS both prior to the HIV/AIDS epidemic and with HIV/AIDS suggest the presence of an additional co-factor in the development of KS.

Methods

Between January 1994 and October 1997, we interviewed 2576 black in-patients with cancer in Johannesburg and Soweto, South Africa. Blood was tested for antibodies against HIV-1 and HHV-8 and the study was restricted to 2191 HIV-1 negative patients. Antibodies against the latent nuclear antigen of HHV-8 encoded by orf73 were detected with an indirect immunofluorescence assay. We examined the relationship between high anti-HHV-8 antibody titers (≥1:51,200) and sociodemographic and behavioral factors using unconditional logistic regression models. Variables that were significant at p = 0.10 were included in multivariate analysis.

Results

Of the 2191 HIV-1 negative patients who did not have Kaposi's sarcoma, 854 (39.0%) were positive for antibodies against HHV-8 according to the immunofluorescent assay. Among those seropositive for HHV-8, 530 (62.1%) had low titers (1:200), 227 (26.6%) had medium titers (1:51,200) and 97 (11.4%) had highest titers (1:204,800). Among the 2191 HIV-1 negative patients, the prevalence of high anti-HHV-8 antibody titers (≥1:51,200) was independently associated with increasing age (ptrend = 0.04), having a marital status of separated or divorced (p = 0.003), using wood, coal or charcoal as fuel for cooking 20 years ago instead of electricity (p = 0.02) and consuming traditional maize beer more than one time a week (p = 0.02; p-trend for increasing consumption = 0.05) although this may be due to chance given the large number of predictors considered in this analysis.

Conclusions

Among HIV-negative subjects, patients with high anti-HHV-8 antibody titers are characterized by older age. Other associations that may be factors in the development of high anti-HHV-8 titers include exposure to poverty or a low socioeconomic status environment and consumption of traditional maize beer. The relationship between these variables and high anti-HHV-8 titers requires further, prospective study.
Literature
1.
go back to reference Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994, 266: 1865-9.CrossRefPubMed Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994, 266: 1865-9.CrossRefPubMed
2.
go back to reference Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996, 2: 925-8.CrossRefPubMed Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996, 2: 925-8.CrossRefPubMed
3.
go back to reference Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995, 346: 799-802. 10.1016/S0140-6736(95)91619-9.CrossRefPubMed Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995, 346: 799-802. 10.1016/S0140-6736(95)91619-9.CrossRefPubMed
4.
go back to reference Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1995, 1: 1274-8.CrossRefPubMed Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1995, 1: 1274-8.CrossRefPubMed
5.
go back to reference Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 1997, 71: 715-9.PubMedPubMedCentral Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 1997, 71: 715-9.PubMedPubMedCentral
6.
go back to reference Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y: Kaposi's sarcoma-associated herpesviurs infection prior to onset of Kaposi's sarcoma. AIDS. 1996, 10: 175-180.CrossRefPubMed Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y: Kaposi's sarcoma-associated herpesviurs infection prior to onset of Kaposi's sarcoma. AIDS. 1996, 10: 175-180.CrossRefPubMed
7.
go back to reference Dedicoat M, Newton R: Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. British Journal of Cancer. 2003, 88: 1-3. 10.1038/sj.bjc.6600745.CrossRefPubMedPubMedCentral Dedicoat M, Newton R: Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. British Journal of Cancer. 2003, 88: 1-3. 10.1038/sj.bjc.6600745.CrossRefPubMedPubMedCentral
8.
go back to reference Grossman Z, Iscovich J, Schwartz F, Azizi E, Klepfish A, Schattner A, Sarid R: Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc. 2002, 77 (9): 905-9.CrossRefPubMed Grossman Z, Iscovich J, Schwartz F, Azizi E, Klepfish A, Schattner A, Sarid R: Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc. 2002, 77 (9): 905-9.CrossRefPubMed
9.
go back to reference Greenblatt R: Kaposi's sarcoma and human herpesvirus-8. Infect Dis Clin North Am. 1998, 12 (1): 63-82.CrossRefPubMed Greenblatt R: Kaposi's sarcoma and human herpesvirus-8. Infect Dis Clin North Am. 1998, 12 (1): 63-82.CrossRefPubMed
10.
go back to reference Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R: Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 2000, 88 (3): 500-17. 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0.CrossRefPubMed Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R: Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 2000, 88 (3): 500-17. 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0.CrossRefPubMed
11.
go back to reference Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R, Beral V: Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS. 1997, 11: 1619-1626. 10.1097/00002030-199713000-00011.CrossRefPubMed Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R, Beral V: Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS. 1997, 11: 1619-1626. 10.1097/00002030-199713000-00011.CrossRefPubMed
12.
go back to reference Ziegler JL, Simonart T, Snoeck R: Kaposi's saroma, oncogenic viruses and iron. Journal of Clinical Virology. 2001, 20: 127-130. 10.1016/S1386-6532(00)00137-2.CrossRefPubMed Ziegler JL, Simonart T, Snoeck R: Kaposi's saroma, oncogenic viruses and iron. Journal of Clinical Virology. 2001, 20: 127-130. 10.1016/S1386-6532(00)00137-2.CrossRefPubMed
13.
go back to reference Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: Risk factors for Kaposi's sarcoma: A Case-control study of HIV-seronegative people in Uganda. International Journal of Cancer. 2003, 103: 233-240. 10.1002/ijc.10818.CrossRefPubMed Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: Risk factors for Kaposi's sarcoma: A Case-control study of HIV-seronegative people in Uganda. International Journal of Cancer. 2003, 103: 233-240. 10.1002/ijc.10818.CrossRefPubMed
14.
go back to reference Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R: Antibodies against human herpesviurs 8 in black South African patients with cancer. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med. 1999, 340 (24): 1863-71. 10.1056/NEJM199906173402403.CrossRefPubMed Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R: Antibodies against human herpesviurs 8 in black South African patients with cancer. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med. 1999, 340 (24): 1863-71. 10.1056/NEJM199906173402403.CrossRefPubMed
15.
go back to reference Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B: Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999, 91 (17): 1468-74. 10.1093/jnci/91.17.1468.CrossRefPubMed Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B: Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999, 91 (17): 1468-74. 10.1093/jnci/91.17.1468.CrossRefPubMed
16.
go back to reference Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J: Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol. 2001, 39 (12): 4269-73. 10.1128/JCM.39.12.4269-4273.2001.CrossRefPubMedPubMedCentral Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J: Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol. 2001, 39 (12): 4269-73. 10.1128/JCM.39.12.4269-4273.2001.CrossRefPubMedPubMedCentral
17.
go back to reference Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ: Antibody Reactivity to Latent and Lytic Antigens to Human Hepesvirus-8 in Longitudinally Followed Homosexual Men. Journal of Infectious Disease. 2003, 187: 1218-CrossRef Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ: Antibody Reactivity to Latent and Lytic Antigens to Human Hepesvirus-8 in Longitudinally Followed Homosexual Men. Journal of Infectious Disease. 2003, 187: 1218-CrossRef
18.
go back to reference Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: The seroepidemiology of Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer. 2003, 103: 226-232. 10.1002/ijc.10817.CrossRefPubMed Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: The seroepidemiology of Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer. 2003, 103: 226-232. 10.1002/ijc.10817.CrossRefPubMed
19.
go back to reference Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 1998, 91: 1671-9. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 1998, 91: 1671-9.
20.
go back to reference Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996, 348: 1133-8. 10.1016/S0140-6736(96)07560-5.CrossRefPubMed Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996, 348: 1133-8. 10.1016/S0140-6736(96)07560-5.CrossRefPubMed
21.
go back to reference Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996, 2: 918-924. [Erratum, Nat Med 1996; 2: 1041]CrossRefPubMed Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996, 2: 918-924. [Erratum, Nat Med 1996; 2: 1041]CrossRefPubMed
22.
go back to reference Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF: The 222 to 234-kilodalton laten nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virology. 1997, 71: 5915-5921.PubMedPubMedCentral Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF: The 222 to 234-kilodalton laten nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virology. 1997, 71: 5915-5921.PubMedPubMedCentral
23.
go back to reference Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ: Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virology. 1997, 1: 19-29. Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ: Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virology. 1997, 1: 19-29.
24.
go back to reference Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 1998, 91: 1671-1679.PubMed Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 1998, 91: 1671-1679.PubMed
25.
go back to reference Renwick H, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS. 1998, 12 (18): 2481-8. 10.1097/00002030-199818000-00018.CrossRefPubMed Renwick H, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS. 1998, 12 (18): 2481-8. 10.1097/00002030-199818000-00018.CrossRefPubMed
26.
go back to reference STATA: Stata software. College Park, TX: STATA. 2001 STATA: Stata software. College Park, TX: STATA. 2001
27.
go back to reference Lemeshow S, Hosmer DW: A Review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology. 1982, 115: 92-106.PubMed Lemeshow S, Hosmer DW: A Review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology. 1982, 115: 92-106.PubMed
28.
go back to reference de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978, 274: 756-61.CrossRefPubMed de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978, 274: 756-61.CrossRefPubMed
29.
go back to reference de-The G, Lavoue MF, Muenz L: Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. In: Nasopharyngeal carcinoma: etiology and control. Edited by: de-The, Ito Y. 1978, Lyons, France: International Agency for Research on Cancer, (IARC scientific publications no.20.) de-The G, Lavoue MF, Muenz L: Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. In: Nasopharyngeal carcinoma: etiology and control. Edited by: de-The, Ito Y. 1978, Lyons, France: International Agency for Research on Cancer, (IARC scientific publications no.20.)
30.
go back to reference Cook-Mozaffari P, Newton R, Beral V, Burkitt DP: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer. 1998, 78: 1521-8.CrossRefPubMedPubMedCentral Cook-Mozaffari P, Newton R, Beral V, Burkitt DP: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer. 1998, 78: 1521-8.CrossRefPubMedPubMedCentral
31.
go back to reference Plancoulaine S, Abel L, van Beveren M, Gessain A: High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. Journal of the National Cancer Institute. 2002, 94 (7): 133-5. Plancoulaine S, Abel L, van Beveren M, Gessain A: High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. Journal of the National Cancer Institute. 2002, 94 (7): 133-5.
32.
go back to reference Vitale F, Briffa DV, Whitby D, Maida I, Grochowska A, Levin A, Romano N, Goedert JJ: Annual Incidence Rates of Classical KS in 3 Mediterranean Islands. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. International Journal of Cancer. 2001, 91: 588-591. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1089>3.0.CO;2-8.CrossRefPubMed Vitale F, Briffa DV, Whitby D, Maida I, Grochowska A, Levin A, Romano N, Goedert JJ: Annual Incidence Rates of Classical KS in 3 Mediterranean Islands. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. International Journal of Cancer. 2001, 91: 588-591. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1089>3.0.CO;2-8.CrossRefPubMed
33.
go back to reference Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L, Uccella I, et al: Infection with Human Herpesvirus Type 8 and Kaposi's Sarcoma in a Central Italian Area Formerly Endemic for Malaria. Infection. 2003, 31 (1): 47-50.CrossRefPubMed Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L, Uccella I, et al: Infection with Human Herpesvirus Type 8 and Kaposi's Sarcoma in a Central Italian Area Formerly Endemic for Malaria. Infection. 2003, 31 (1): 47-50.CrossRefPubMed
34.
go back to reference Statistics South Africa: Census in Brief. Pretoria: Statistics – SA. 1996 Statistics South Africa: Census in Brief. Pretoria: Statistics – SA. 1996
35.
go back to reference Stowe RP, Pierson DL, Feeback DL, Barrett AD: Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation. 2000, 8 (2): 51-8. 10.1159/000026453.CrossRefPubMed Stowe RP, Pierson DL, Feeback DL, Barrett AD: Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation. 2000, 8 (2): 51-8. 10.1159/000026453.CrossRefPubMed
36.
go back to reference Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001, 15 (3): 199-226. 10.1006/brbi.2000.0597.CrossRefPubMed Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001, 15 (3): 199-226. 10.1006/brbi.2000.0597.CrossRefPubMed
37.
go back to reference Gordeuk VR, Brittenham GML: Iron overload – still a problem among the Zulus. South African Medical Journal. 1986, 603-4. Gordeuk VR, Brittenham GML: Iron overload – still a problem among the Zulus. South African Medical Journal. 1986, 603-4.
38.
go back to reference Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N: Iron overload in Bantu subjects. American Journal of Clinical Nutrition. 1964, 14: 47-51.PubMed Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N: Iron overload in Bantu subjects. American Journal of Clinical Nutrition. 1964, 14: 47-51.PubMed
39.
go back to reference Baker LD: Alcohol consumption among South African blacks and its relationship to iron overload. South African Medical Journal. 1986, 70: 160-2.PubMed Baker LD: Alcohol consumption among South African blacks and its relationship to iron overload. South African Medical Journal. 1986, 70: 160-2.PubMed
40.
go back to reference Bothwell TH, Charlton RW, Sewftel HC: Oral iron overload. South African Medical Journal. 1965, 892-900. Bothwell TH, Charlton RW, Sewftel HC: Oral iron overload. South African Medical Journal. 1965, 892-900.
41.
go back to reference Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, Romano N, Classical Kaposi's Sarcoma Working Group: Risk factors for classical Kaposi's sarcoma. Journal of the National Cancer Institute. 2002, 94 (22): 1712-8. 10.1093/jnci/94.22.1712.CrossRefPubMed Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, Romano N, Classical Kaposi's Sarcoma Working Group: Risk factors for classical Kaposi's sarcoma. Journal of the National Cancer Institute. 2002, 94 (22): 1712-8. 10.1093/jnci/94.22.1712.CrossRefPubMed
42.
go back to reference Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, Macfarlane BJ, Lamparelli RD, Robinson EJ, Sher R, Hamberg S: Dietary iron overload in southern African rural blacks. South African Medical Journal. 1990, 78: 301-5.PubMed Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, Macfarlane BJ, Lamparelli RD, Robinson EJ, Sher R, Hamberg S: Dietary iron overload in southern African rural blacks. South African Medical Journal. 1990, 78: 301-5.PubMed
Metadata
Title
Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study
Authors
Janet M Wojcicki
Rob Newton
Margaret I Urban
Lara Stein
Martin Hale
Moosa Patel
Paul Ruff
Ranjan Sur
Dimitra Bourboulia
Freddy Sitas
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2003
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-3-21

Other articles of this Issue 1/2003

BMC Infectious Diseases 1/2003 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.